Merck Life Science Private Limited

Merck Life Science Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U33100MH1986PTC221693 Incorporated 03 September 1986 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹2,200.06 Cr
▲ 7% YoY
Net profit · FY 2025
₹127.97 Cr
Net margin 5.8%
EBITDA · FY 2025
₹229.32 Cr
EBITDA margin 10.4%
Authorised capital
₹2.25 Cr
Registered with MCA
Paid-up capital
₹2.22 Cr
Issued & subscribed
Open charges
₹27.3 Cr
Secured borrowings
Company age
40 yrs
Est. 1986
Employees · EPFO
618
Provident fund records

About Merck Life Science Private Limited

Data last updated:

Merck Life Science Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Sigma-Aldrich Pte Limited, Singapore. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 September 1986 and has been in existence for over 40 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33100MH1986PTC221693. Its GSTIN is 27AACCM1226B1Z4 (Maharashtra). The company holds 14 GST registrations, of which 10 are active.

The company has an authorised share capital of ₹2.25 Cr and a paid-up capital of ₹2.22 Cr. It was formerly known as Millipore (India) Limited and Millipore Asia Limited. It is led by directors Dhananjay Singh (Managing Director) and Pankaj Kumar Joshi.

Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Godrej One 8th Floor Pirojshanagar Eastern Express Highway Vikhroli – East, Mumbai, Maharashtra, India – 400079.

As per the financials filed for FY 2025, the company reported a revenue of ₹2,200.06 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹127.97 Cr (net margin 5.8%) and EBITDA of ₹229.32 Cr (EBITDA margin 10.4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 13% over five years.

The company has about 618 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Merck. As per MCA filings, the company has open charges of ₹27.3 Cr on record. Court records list 107 cases involving the company, including 63 filed by the company and 44 filed against it; 13 cases are pending. The company has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in January 2019. The company has 21 MSME Form 1 returns on record between 2015 and 2024, listing 247 overdue payments to 77 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website merckgroup.com.

Company details

CIN U33100MH1986PTC221693
Registration Number 221693
Incorporation Date 03 September 1986
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Sigma-Aldrich Pte Limited, Singapore
Compliance Status Active Compliant

Name history

Merck Life Science has undergone 3 name changes throughout its history. The company was previously known as Millipore (India) Limited, Millipore Asia Limited, and Millipore (India) Private Limited. The current legal name is Merck Life Science Private Limited.

Company NameStatus
Merck Life Science Private LimitedCurrent
Millipore (India) LimitedPrevious
Millipore Asia LimitedPrevious
Millipore (India) Private LimitedPrevious

CIN history

Merck Life Science has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U33100MH1986PTC221693, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U33100MH1986PTC221693Current
U33100KA1986PTC007759Previous
U85110KA1986PTC007759Previous

Contact details

Merck Life Science Private Limited's registered office is in Mumbai, Maharashtra. Its website is merckgroup.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Godrej One 8th Floor Pirojshanagar Eastern Express Highway Vikhroli – East, Mumbai, Maharashtra, India – 400079
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Merck Life Science Private Limited, buy the company report.

Comprehensive company report
Merck Life Science Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Merck Life Science operates one associated brand: Merck. Each brand links to its own profile.

BrandDescriptionWebsite
Merck is engaged in science and technology solutions globally.merckgroup.com

Business activity

The main business activities of Merck Life Science are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Merck Life Science Private Limited, buy the company report.

Financials of Merck Life Science Private Limited

FY 2025 filings available

Merck Life Science Private Limited reported revenue of ₹2,200.06 Cr (up 7% YoY) for FY 2025.

Revenue · FY 2025
₹2,200.06 Cr ▲ 7%
Net profit · FY 2025
₹127.97 Cr margin 5.8%
EBITDA · FY 2025
₹229.32 Cr margin 10.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 3%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▼ 26%
3 years · compounded
▼ 9%
5 years · compounded
▲ 8%

Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 7% growth in the latest year. EBITDA fell 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹2,200.06 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹229.32 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹127.97 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin10.4%
Net Profit Margin5.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Merck Life Science Private Limited, buy the company report.

Board of directors of Merck Life Science Private Limited

Merck Life Science has 2 current directors and 28 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Pankaj Kumar JoshiAdditional Director30 Jan 20260 Years 9 MonthsCurrent
Dhananjay SinghManaging Director01 Apr 20242 Years 7 MonthsCurrent

Auditor

Merck Life Science Private Limited is audited by B S R & Co Llp for the financial year 2023.

Auditor firmFinancial yearFirm registration number
B S R & Co LlpFY 2023101248W/W-100022

Shareholding

The shareholding of Merck Life Science Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Merck Life Science Private Limited, buy the company report.

Charges & borrowings

Open charges
₹27.3 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹25.20 Cr
Canara Bank₹2.10 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 Jul 199790194100State Bank of India₹24 CrOpen
26 Jul 199390193733State Bank of India₹1.2 CrOpen
24 Dec 199090193570Canara Bank₹1 CrOpen
24 Feb 199090193520Canara Bank₹1 CrOpen
08 Jul 198990193474Canara Bank₹10 LakhOpen

To see the full charge records of Merck Life Science Private Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Merck Life Science Private Limited has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in January 2019.

Total deals
3
Rights issues
2
Secondary share transfer
1

Deals on record (3 of 3)

WhenDealAmountParties
Jan 2019Rights issue₹346.82 CrInvestors: Sigma Aldrich Pte Limited, Merck Life Science Private Limited
Dec 2017Rights issue₹423.41 CrInvestors: Sigma Aldrich Pte Limited, Merck Life Science Private Limited
Seller: Millioore Mauritius Limited
Mar 2010Secondary share transferUndisclosedBuyer: Millioore Mauritius Limited
Seller: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Merck Life Science Private Limited has 21 MSME Form 1 returns on record between 2015 and 2024, listing 247 overdue payments to 77 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 77)

SupplierAmount dueDue sinceReported on
an individual supplier
an individual supplier
Aleph Accreditation and Testing Centre Private Limited
an individual supplier
an individual supplier

To see the full MSME payment records of Merck Life Science Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Merck Life Science Private Limited has a workforce of 618 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.

Employee count
618
Active EPFO establishments
1
Employee growth
-1.9%

GST

Merck Life Science has 14 GST registrations: 10 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
14
Active
10
Cancelled / inactive
4
GSTINStateStatusRegistered on
27AACCM1226B1Z4MaharashtraActive01 Jul 2017
27AACCM1226B3Z2MaharashtraActive10 Nov 2017
07AACCM1226B2Z5DelhiActive01 Jul 2017
19AACCM1226B1Z1West BengalActive01 Jul 2017

To see the full GST registrations and return filing status of Merck Life Science Private Limited, buy the company report.

Recent activity

Merck Life Science Private Limited has 29 board changes on record since 2007: 2 appointments and 27 cessations. The latest: Pankaj Kumar Joshi was appointed as Additional Director on 30 Jan 2026.

Appointed
Pankaj Kumar Joshi was appointed as Additional Director.
AGM
Merck Life Science Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Filing
Merck Life Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Dhananjay Singh was appointed as Managing Director.
Ceased
Dhananjay Singh ceased to be Additional Director.
Ceased
Narayanaiah Sainath Sreenath ceased to be Managing Director.
Ceased
Sunil Punjabi ceased to be Managing Director.
Ceased
Aditya Sharma ceased to be Additional Director.
Ceased
Rahul Tibrewal ceased to be Company Secretary.
Ceased
Kevin Leo Gorman ceased to be Director.
Ceased
Prabhat Verma ceased to be Additional Director.
Ceased
Peter Joseph Salazar ceased to be Director.

28 earlier events are in the company report.

Frequently asked questions

Merck Life Science is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 September 1986 (40+ years old) and is registered under CIN U33100MH1986PTC221693.

Merck Life Science has 2 current directors:

The latest financial statements of Merck Life Science on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Merck Life Science is 27AACCM1226B1Z4, registered in Maharashtra. The company has 14 GST registrations in all, of which 10 are active and 4 are cancelled or inactive. Other active GSTINs include 27AACCM1226B3Z2 (Maharashtra), 07AACCM1226B2Z5 (Delhi), 19AACCM1226B1Z1 (West Bengal).

The CIN (Corporate Identification Number) of Merck Life Science is U33100MH1986PTC221693. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Merck Life Science has 107 court cases on record: 63 filed by the company and 44 filed against it. 13 are pending. Most are in the high courts.

Merck Life Science was incorporated on 03 September 1986, making it 40+ years old. It is registered with the Registrar of Companies, Mumbai.

Merck Life Science has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in January 2019.

Pankaj Kumar Joshi was appointed as Additional Director on 30 Jan 2026. Dhananjay Singh was appointed as Managing Director on 01 Apr 2024. Dhananjay Singh ceased to be Additional Director on 01 Apr 2024. Merck Life Science has 29 board changes on record in total.

Merck Life Science has 21 MSME Form 1 returns on record between 2015 and 2024, listing 247 overdue payments to 77 micro and small suppliers. The latest return was filed on 23 Apr 2024.

Merck Life Science can be reached through the website merckgroup.com. Its registered office is in Mumbai, Maharashtra, India.